Approach to Changing Anti-Seizure Medication for Patients Who Don't Tolerate Levetiracetam

Assessment and Preferred Alternatives

When switching from levetiracetam due to intolerance, lamotrigine or lacosamide should be considered as preferred alternatives due to their favorable efficacy and tolerability profiles, according to the American College of Neurology 1
Review the patient's seizure type, as medication selection should be tailored to the specific seizure classification, as recommended by the American Academy of Neurology 1
Evaluate for any comorbidities that might influence medication choice, such as pregnancy considerations or intellectual disability, as suggested by the American College of Obstetricians and Gynecologists 2

The overlap method is the preferred approach for switching, where the new anti-seizure medication is started while maintaining the current levetiracetam dose, and then gradually titrated to an effective dose, as recommended by the American Academy of Emergency Medicine 3, 1
For severe adverse reactions, consider hospitalization for monitoring during the switch, and use loading doses of the new agent when available, as suggested by the American College of Emergency Physicians 2, 3, 4
Avoid valproic acid in pregnancy, and consider lamotrigine as a preferred alternative, but with dose adjustments, as recommended by the American College of Obstetricians and Gynecologists 2, 1

Schedule follow-up within 2-4 weeks of initiating the new medication to assess for seizure control and new adverse effects, as recommended by the American Academy of Neurology 1
Consider serum drug levels if compliance is a concern or to assess for toxicity with certain medications, as suggested by the American College of Clinical Pharmacology 1
Educate patients about potential side effects of the new medication and when to seek medical attention, as recommended by the American College of Physicians 2
Never stop levetiracetam suddenly, as this may precipitate withdrawal seizures, as warned by the American Academy of Emergency Medicine 3
Aim for monotherapy rather than polytherapy to minimize side effects, as recommended by the American Academy of Neurology 2, 1

In cases of severe bruising or significant thrombocytopenia, the American College of Emergency Physicians recommends considering hospitalization for monitored transition with loading doses of the new agent when available, with a strength of evidence based on clinical experience 5, 6
More rapid levetiracetam discontinuation may be warranted in severe cases, but it is crucial to maintain seizure protection with adequate dosing of the new medication, as suggested by the American College of Emergency Physicians 5